Free tool
Healthcare stocks
We cover 283 companies in the Healthcare sector. The median market value in the group is $2.26B. Across the group, the median move over the past trading day is −0.31%. 60% of the 277 with a 200-day average trade above it. Price change over the past year runs from −75.5% to +217.6% across the middle 80 percent of the group, with a median of +8.7%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
283 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% | Nov 5, 2026 |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% | Oct 28, 2026 |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% | Nov 5, 2026 |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% | Nov 9, 2026 |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% | Nov 16, 2026 |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% | Nov 3, 2026 |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% | Nov 9, 2026 |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% | Nov 4, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% | Nov 5, 2026 |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% | Aug 27, 2026 |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% | Nov 3, 2026 |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% | Oct 29, 2026 |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% | Nov 2, 2026 |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% | Nov 5, 2026 |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% | Oct 28, 2026 |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% | Nov 3, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% | Nov 3, 2026 |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% | Nov 4, 2026 |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% | Nov 12, 2026 |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% | Nov 3, 2026 |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% | Oct 27, 2026 |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% | Nov 9, 2026 |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% | Nov 9, 2026 |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% | Nov 9, 2026 |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% | Nov 11, 2026 |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% | Nov 5, 2026 |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% | Nov 11, 2026 |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% | Nov 3, 2026 |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% | Nov 3, 2026 |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% | Nov 9, 2026 |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% | Nov 3, 2026 |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% | Oct 29, 2026 |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% | Oct 29, 2026 |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% | Nov 2, 2026 |
| BLCO.TO | Bausch + Lomb Corporation | $6.18B | Mid cap | +19.34% | Oct 28, 2026 |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% | Oct 28, 2026 |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% | Nov 5, 2026 |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% | Nov 5, 2026 |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% | Nov 5, 2026 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% | Oct 27, 2026 |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% | Nov 5, 2026 |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% | Nov 4, 2026 |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% | Nov 5, 2026 |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% | Oct 29, 2026 |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% | Nov 5, 2026 |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% | Nov 9, 2026 |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% | Nov 3, 2026 |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% | Sep 1, 2026 |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% | Oct 29, 2026 |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% | Nov 4, 2026 |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% | Nov 5, 2026 |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% | Nov 5, 2026 |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% | Nov 5, 2026 |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% | Nov 5, 2026 |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% | Nov 11, 2026 |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% | Oct 28, 2026 |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% | Nov 5, 2026 |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% | Nov 5, 2026 |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% | Oct 28, 2026 |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% | Nov 11, 2026 |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% | Nov 5, 2026 |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% | Nov 5, 2026 |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% | Nov 4, 2026 |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% | Nov 12, 2026 |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% | Nov 4, 2026 |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% | Nov 5, 2026 |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% | Nov 11, 2026 |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% | Oct 29, 2026 |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% | Nov 5, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% | Nov 4, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% | Nov 5, 2026 |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% | Nov 5, 2026 |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% | Nov 11, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% | Nov 9, 2026 |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% | Oct 28, 2026 |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% | Nov 5, 2026 |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% | Nov 5, 2026 |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% | Oct 27, 2026 |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% | Nov 5, 2026 |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% | Nov 9, 2026 |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% | Oct 29, 2026 |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% | Nov 3, 2026 |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% | Nov 5, 2026 |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% | Nov 11, 2026 |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% | Nov 9, 2026 |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% | Nov 6, 2026 |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% | Nov 5, 2026 |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% | Nov 5, 2026 |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% | Nov 5, 2026 |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% | Nov 4, 2026 |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% | Nov 5, 2026 |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% | Nov 3, 2026 |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% | Oct 29, 2026 |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% | Nov 9, 2026 |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% | Nov 5, 2026 |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% | Nov 5, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% | Oct 27, 2026 |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% | Nov 4, 2026 |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% | Nov 12, 2026 |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% | Oct 27, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% | Nov 5, 2026 |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% | Nov 5, 2026 |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% | Oct 29, 2026 |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% | Nov 4, 2026 |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% | Nov 11, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% | Nov 12, 2026 |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% | Oct 28, 2026 |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −3.13% | Nov 5, 2026 |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% | Oct 27, 2026 |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% | Oct 28, 2026 |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% | Nov 5, 2026 |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% | Nov 12, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% | Nov 3, 2026 |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% | Nov 3, 2026 |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% | Nov 12, 2026 |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% | Nov 9, 2026 |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% | Nov 12, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% | Nov 5, 2026 |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% | Nov 12, 2026 |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% | Nov 2, 2026 |
| CURA.TO | Curaleaf Holdings, Inc. | $2.51B | Mid cap | +197.74% | Nov 4, 2026 |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% | Nov 12, 2026 |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% | Nov 5, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% | Nov 2, 2026 |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% | Oct 28, 2026 |
| BHC.TO | Bausch Health Companies Inc. | $2.43B | Mid cap | −9.88% | Oct 28, 2026 |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | −29.08% | Oct 29, 2026 |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% | Nov 4, 2026 |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +54.91% | Nov 5, 2026 |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% | Nov 9, 2026 |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% | Nov 2, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% | Nov 3, 2026 |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% | Oct 30, 2026 |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% | Nov 16, 2026 |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% | Nov 10, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% | Sep 29, 2026 |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% | Nov 4, 2026 |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% | Nov 2, 2026 |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% | Nov 5, 2026 |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% | Aug 27, 2026 |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% | Nov 11, 2026 |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% | Nov 9, 2026 |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% | Nov 2, 2026 |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% | Nov 5, 2026 |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% | Nov 11, 2026 |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% | Nov 5, 2026 |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% | Nov 4, 2026 |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% | Nov 12, 2026 |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% | Nov 4, 2026 |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% | Nov 3, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% | Nov 4, 2026 |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% | Nov 5, 2026 |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% | Oct 29, 2026 |
| GENB | Generate Biomedicines, Inc. | $2.07B | Mid cap | +27.59% | Nov 5, 2026 |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% | Nov 4, 2026 |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% | Nov 4, 2026 |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% | Oct 29, 2026 |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% | Nov 3, 2026 |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% | Nov 12, 2026 |
| ACH | Accendra Health, Inc. | $93.82M | Micro cap | −75.05% | Oct 29, 2026 |
| ALDX | Aldeyra Therapeutics, Inc. | $93.51M | Micro cap | −73.33% | Nov 4, 2026 |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% | Nov 4, 2026 |
| HYPR | Hyperfine, Inc. | $92.06M | Micro cap | −29.99% | Nov 12, 2026 |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% | Nov 12, 2026 |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $90.10M | Micro cap | −11.35% | Nov 11, 2026 |
| CWEB.TO | Charlotte's Web Holdings, Inc. | $88.25M | Micro cap | +253.85% | Nov 11, 2026 |
| CVRX | CVRx, Inc. | $87.12M | Micro cap | −56.75% | Nov 5, 2026 |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% | Nov 4, 2026 |
| VRCA | Verrica Pharmaceuticals Inc. | $84.35M | Micro cap | −13.25% | Nov 13, 2026 |
| DH | Definitive Healthcare Corp. | $84.34M | Micro cap | −80.44% | Nov 5, 2026 |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% | Nov 11, 2026 |
| RPID | Rapid Micro Biosystems, Inc. | $83.77M | Micro cap | −34.77% | Nov 6, 2026 |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% | Nov 16, 2026 |
| HLS.TO | HLS Therapeutics Inc. | $81.35M | Micro cap | −30.48% | Nov 12, 2026 |
| OM | Outset Medical, Inc. | $79.89M | Micro cap | −69.56% | Nov 9, 2026 |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% | Nov 16, 2026 |
| CRDF | Cardiff Oncology, Inc. | $76.56M | Micro cap | −54.65% | Nov 12, 2026 |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% | Nov 5, 2026 |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% | Nov 12, 2026 |
| MDXH | MDxHealth SA | $72.15M | Micro cap | −84.51% | Nov 12, 2026 |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% | Nov 12, 2026 |
| ZTEK | Zentek Ltd. | $70.91M | Micro cap | −17.65% | Nov 12, 2026 |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% | Nov 16, 2026 |
| DRIO | DarioHealth Corp. | $68.89M | Micro cap | −26.92% | Nov 12, 2026 |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% | Sep 9, 2026 |
| CSBR | Champions Oncology, Inc. | $68.36M | Micro cap | −25.45% | Sep 14, 2026 |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% | Oct 29, 2026 |
| HYFT | MindWalk Holdings Corp. | $67.19M | Micro cap | −46.04% | Sep 14, 2026 |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% | Nov 11, 2026 |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% | Nov 9, 2026 |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% | Nov 12, 2026 |
| HRTX | Heron Therapeutics, Inc. | $59.27M | Micro cap | −77.04% | Nov 3, 2026 |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% | Nov 4, 2026 |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% | Sep 2, 2026 |
| SRTS | Sensus Healthcare, Inc. | $54.16M | Micro cap | +3.46% | Nov 5, 2026 |
| ATYR | aTyr Pharma, Inc. | $54.05M | Micro cap | −89.34% | Nov 5, 2026 |
| HYPD | Hyperion DeFi, Inc. | $52.68M | Micro cap | −50.87% | Nov 12, 2026 |
| BTMD | biote Corp. | $52.54M | Micro cap | −53.87% | Nov 4, 2026 |
| MDAI | Spectral AI, Inc. | $51.82M | Micro cap | −23.33% | Nov 10, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% | Oct 30, 2026 |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% | Nov 12, 2026 |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% | Nov 4, 2026 |
| POCI | Precision Optics Corporation, Inc. | $47.61M | Micro cap | −12.30% | Sep 28, 2026 |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% | Nov 5, 2026 |
| QTI | QT Imaging Holdings, Inc. | $46.40M | Micro cap | −91.44% | Nov 10, 2026 |
| FLNA | Filana Therapeutics, Inc. | $45.83M | Micro cap | −59.98% | Oct 29, 2026 |
| XTNT | Xtant Medical Holdings, Inc. | $45.03M | Micro cap | −47.38% | Nov 10, 2026 |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% | Nov 3, 2026 |
| MREO | Mereo BioPharma Group plc | $44.39M | Micro cap | −84.20% | Nov 9, 2026 |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% | Nov 12, 2026 |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% | Nov 5, 2026 |
| TVGN | Tevogen Inc. | $43.63M | Micro cap | −85.43% | Nov 13, 2026 |
| PAVM | PAVmed Inc. | $42.54M | Micro cap | −63.21% | Nov 12, 2026 |
| SNWV | SANUWAVE Health, Inc. | $41.89M | Micro cap | −89.02% | Nov 6, 2026 |
| NSPR | InspireMD, Inc. | $41.69M | Micro cap | −63.52% | Nov 10, 2026 |
| CRVO | CervoMed Inc. | $40.07M | Micro cap | −71.78% | Nov 12, 2026 |
| DCGO | DocGo Inc. | $39.10M | Micro cap | −75.60% | Nov 9, 2026 |
| PETS | PetMed Express, Inc. | $38.81M | Micro cap | −43.35% | Nov 16, 2026 |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% | Nov 5, 2026 |
| LITS | Lite Strategy, Inc. | $33.79M | Micro cap | −80.75% | Sep 28, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% | Nov 9, 2026 |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% | Nov 11, 2026 |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% | Nov 12, 2026 |
| ARAY | Accuray Incorporated | $31.57M | Micro cap | −83.17% | Nov 4, 2026 |
| MDNA.TO | Medicenna Therapeutics Corp. | $31.26M | Micro cap | −56.48% | Nov 12, 2026 |
| TELA | TELA Bio, Inc. | $31.03M | Micro cap | −60.73% | Nov 12, 2026 |
| SVA.TO | Sernova Biotherapeutics Inc | $29.93M | Micro cap | −42.11% | Sep 10, 2026 |
| BYSI | BeyondSpring Inc. | $28.37M | Micro cap | −62.09% | Nov 12, 2026 |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −46.17% | Nov 11, 2026 |
| BEAT | HeartBeam, Inc. | $27.13M | Micro cap | −59.20% | Nov 12, 2026 |
| DYAI | Dyadic International, Inc. | $26.45M | Micro cap | −29.02% | Nov 11, 2026 |
| RVX.TO | Resverlogix Corp. | $24.81M | Micro cap | 0.00% | Nov 12, 2026 |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −47.30% | Nov 12, 2026 |
| JSPR | Jasper Therapeutics, Inc. | $23.96M | Micro cap | −75.24% | Nov 10, 2026 |
| TVRD | Tvardi Therapeutics, Inc. | $23.74M | Micro cap | −94.18% | Nov 12, 2026 |
| LABS.TO | MediPharm Labs Corp. | $23.16M | Micro cap | +6.67% | Nov 12, 2026 |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% | Nov 11, 2026 |
| CTSO | Cytosorbents Corporation | $22.62M | Micro cap | −61.29% | Nov 12, 2026 |
| LGVN | Longeveron Inc. | $21.68M | Micro cap | −14.44% | Nov 4, 2026 |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% | Nov 12, 2026 |
| TPST | Tempest Therapeutics, Inc. | $17.86M | Micro cap | −89.96% | Nov 5, 2026 |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% | Nov 9, 2026 |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −30.40% | Nov 5, 2026 |
| DARE | Daré Bioscience, Inc. | $14.54M | Micro cap | −62.84% | Nov 12, 2026 |
| BNGO | Bionano Genomics, Inc. | $14.25M | Micro cap | −68.97% | Nov 12, 2026 |
| AVCN.TO | Avicanna Inc. | $12.59M | Micro cap | −52.73% | Nov 13, 2026 |
| PDSB | PDS Biotechnology Corporation | $12.49M | Micro cap | −82.56% | Nov 12, 2026 |
| IRIX | IRIDEX Corporation | $12.31M | Micro cap | −45.58% | Nov 17, 2026 |
| BLRX | BioLineRx Ltd. | $11.79M | Micro cap | −26.63% | Aug 31, 2026 |
| VTGN | Vistagen Therapeutics, Inc. | $11.54M | Micro cap | −91.82% | Nov 12, 2026 |
| AMS | American Shared Hospital Services | $10.04M | Micro cap | −38.62% | Nov 12, 2026 |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −89.34% | Sep 28, 2026 |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% | Nov 12, 2026 |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% | Nov 9, 2026 |
| CODX | Co-Diagnostics, Inc. | $8.73M | Micro cap | −87.22% | Nov 16, 2026 |
| EVGN | Evogene Ltd. | $8.58M | Micro cap | −58.55% | Nov 19, 2026 |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% | Nov 18, 2026 |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% | Sep 23, 2026 |
| AVNT.TO | Avant Brands Inc. | $6.51M | Micro cap | −28.57% | Oct 15, 2026 |
| ACXP | Acurx Pharmaceuticals, Inc. | $6.15M | Micro cap | −70.64% | Nov 11, 2026 |
| CLGN | CollPlant Biotechnologies Ltd. | $5.81M | Micro cap | −89.43% | Aug 27, 2026 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.71M | Micro cap | −48.46% | Nov 6, 2026 |
| CSCI.TO | COSCIENS Biopharma Inc. | $5.24M | Micro cap | +60.79% | Nov 10, 2026 |
| BCAB | BioAtla, Inc. | $5.20M | Micro cap | −86.04% | Nov 12, 2026 |
| VVOS | Vivos Therapeutics, Inc. | $5.11M | Micro cap | −94.48% | Nov 16, 2026 |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% | Nov 10, 2026 |
| VNRX | VolitionRx Limited | $4.89M | Micro cap | −97.47% | Nov 12, 2026 |
| JAGX | Jaguar Health, Inc. | $4.78M | Micro cap | −98.52% | Nov 12, 2026 |
| XRTX | XORTX Therapeutics Inc. | $4.03M | Micro cap | −43.99% | Nov 12, 2026 |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −5.52% | Nov 5, 2026 |
| REVB | Revelation Biosciences, Inc. | $3.80M | Micro cap | −91.25% | Nov 5, 2026 |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% | Nov 12, 2026 |
| NXGL | NEXGEL, Inc. | $3.47M | Micro cap | −84.79% | Nov 10, 2026 |
| NUWE | Nuwellis, Inc. | $3.21M | Micro cap | −80.39% | Nov 11, 2026 |
| AEMD | Aethlon Medical, Inc. | $1.62M | Micro cap | −85.66% | Nov 11, 2026 |
| APLI.TO | Appili Therapeutics Inc. | $1.44M | Micro cap | −25.00% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.